metsera glp-1 links drug to 11% weight loss after 12 weeks Metsera's GLP-1 Receptor Agonist MET-097i

People with type 2 diabetes may be able to stop taking metformin with the supervision of a doctor

Projections indicate that by 2030, the number of people affected by this ailment is estimated to reach around 366 million [5]

K., Reimann, F., & Liberles, S

9 The Australian Type 2 diabetes glycaemic management algorithm provides stepwise guidance to managing patients that are not meeting HbA1c targets

It has not (yet) been approved for weight management

When to Seek Medical Advice for Semaglutide-Related Fatigue While some minor discomfort and fatigue can occur during the initial phase of your treatment as your body adjusts to the medication, significant, persistent, or worsening tiredness should never be overlooked